Word: latest
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
Stripped of his tuxedo, Aston Martin, and martini, the newest James Bond still maintains an heroic persona in his latest film, “Defiance.” While the movie’s Holocaust setting might arouse the expectation of another horrifying display of Nazi actions (as in “Schindler’s List), director Edward Zwick ’74 (“The Last Samurai,” “Blood Diamond”) surprises the audience by examining the Holocaust from an original angle. In a story of survival, Daniel Craig...
Formed by Max Collins, Jon Siebels, and Tony Fagenson in 1995, Eve 6 disbanded in 2004 after being dropped by their record label, RCA Corporation. The band’s latest tour, launched two years since their 2007 reunion, is scheduled to stop at several other schools in the region, including SUNY Binghamton and the University of Connecticut...
After four years, Franz Ferdinand’s finally returned to the party. “Tonight: Franz Ferdinand,” their third album, finds the Scottish foursome still making dance floor-worthy post-punk. Their latest effort expands their signature style by adding more synthesizers and cranking up the bass in an attempt to satisfy the absurdly high expectations that grew over their long hiatus. However, while “Tonight” is a solid album, it is not as mind-blowingly awesome as it should be. The album’s best tracks showcase Franz Ferdinand...
...love for math and his personal desire to share his awe at its power to explain worldly phenomena. Despite his passion, both Livio’s writing and argument are uneven. At times his prose reads like a history textbook, at others like a review of the latest research in astrophysics. Belying his vigorous attempt to write to the reader, Livio struggles in vain to include sufficient background information necessary for the average reader to match his own remarkable comprehension and unique enthusiasm...
...earlier this week. While at Harvard, Gilliland gained international recognition for discovering the genetic basis of leukemia and served as director of both the Leukemia Program at the Dana-Farber/Harvard Cancer Center and the Cancer Stem Cell Program for the Harvard Stem Cell Institute. Gilliland’s latest work harnessed his earlier findings to explore how drugs could be used to treat leukemia. “His expertise in both basic and translational research will enhance Merck’s efforts to develop innovative and individualized medicines to treat this devastating disease,” said Merck President...